about
Rare cystic liver lesions: a diagnostic and managing challenge.Hedonic eating in Prader-Willi syndrome is associated with blunted PYY secretion.Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease.The gut sensor as regulator of body weight.The use of sibutramine in the management of obesity and related disorders: an update.GrowthHormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome.Proton pump inhibitors: impact on glucose metabolism.Role of SST, CORT and ghrelin and its receptors at the endocrine pancreas.Association between a polymorphic poly-T repeat sequence in the promoter of the somatostatin gene and hypertension.
P2860
Q30446819-975573CC-4AA7-47F1-95A2-67C1E35034ACQ33810957-C55038D2-D88B-4B1D-800A-59AC235BE00BQ33979298-C9A7DD87-1990-4D1E-9682-8DFD96AF3409Q35535513-56D4E73D-E623-4503-B3B0-2D815117A2FCQ37202159-45122CFF-2B2F-4191-8542-95CF7A3A137FQ37213617-07EE50BB-BE87-4F5B-AFB9-020075CAFD92Q38034083-054717F0-56E1-4962-9962-55BDE6E7AA54Q38060718-EF882175-D616-4A25-A82E-F752B18C634BQ48693540-B75E6281-D8C2-45AD-9D21-68FF6B29FF28
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Use of somatostatin analogues in obesity.
@en
Use of somatostatin analogues in obesity.
@nl
type
label
Use of somatostatin analogues in obesity.
@en
Use of somatostatin analogues in obesity.
@nl
prefLabel
Use of somatostatin analogues in obesity.
@en
Use of somatostatin analogues in obesity.
@nl
P2093
P2860
P1433
P1476
Use of somatostatin analogues in obesity.
@en
P2093
Gerasimos E Krassas
Kostas Papazisis
Petros Perros
Themistoklis Tzotzas
P2860
P304
P356
10.2165/00003495-200868140-00003
P577
2008-01-01T00:00:00Z
P6179
1029864224